| Literature DB >> 27593874 |
Dhananjay Yadav1, Dae Ryong Kang2, Sang Baek Koh1,3, Jang Young Kim4, Song Vogue Ahn1,5.
Abstract
PURPOSE: There have been few studies on gender difference in the impact of a urine albumin-to-creatinine ratio (UACR) within the normal range on the risk of hypertension. We evaluated whether the association between the UACR below the microalbuminuria range and the incident risk of hypertension is different between men and women.Entities:
Keywords: Albuminuria; hypertension; prospective study
Mesh:
Substances:
Year: 2016 PMID: 27593874 PMCID: PMC5011278 DOI: 10.3349/ymj.2016.57.6.1454
Source DB: PubMed Journal: Yonsei Med J ISSN: 0513-5796 Impact factor: 2.759
Fig. 1Flowchart of study population. UACR, urine albumin-to-creatinine ratio; KoGES-ARIRANG, Korean Genome and Epidemiology Study on Atherosclerosis Risk of Rural Areas in the Korean General Population.
Baseline Characteristics of Study Subjects with and without Incident Hypertension
| Men | Women | |||||
|---|---|---|---|---|---|---|
| Without incident hypertension | With incident hypertension | Without incident hypertension | With incident hypertension | |||
| n (%) | 385 (87.1) | 57 (12.9) | 665 (91.0) | 66 (9.0) | ||
| Age, yrs | 55.1±8.2 | 56.1±8.8 | 0.425 | 51.9±8.1 | 57.0±8.1 | <0.001 |
| Body mass index, kg/m2 | 23.4±2.8 | 24.5±2.3 | 0.006 | 23.9±3.0 | 25.0±3.0 | 0.007 |
| Muscle mass, kg | 46.5±4.6 | 47.8±4.7 | 0.058 | 35.6±3.9 | 35.8±3.7 | 0.661 |
| Systolic BP, mm Hg | 116.0±9.8 | 120.9±9.1 | <0.001 | 114.3±10.9 | 120.3±10.3 | <0.001 |
| Diastolic BP, mm Hg | 74.6±6.8 | 75.9±6.2 | 0.184 | 72.9±7.6 | 75.3±6.5 | 0.013 |
| Fasting glucose, mg/dL | 95.4±21.6 | 95.3±12.4 | 0.953 | 89.5±10.9 | 90.9±10.3 | 0.308 |
| HDL-cholesterol, mg/dL | 45.1±10.9 | 45.2±11.7 | 0.939 | 48.6±10.3 | 46.6±9.7 | 0.145 |
| LDL-cholesterol, mg/dL | 113.0±31.7 | 117.5±28.2 | 0.306 | 117.0±30.6 | 124.1±29.0 | 0.072 |
| Triglycerides, mg/dL | 122.0 (82.0, 182.0) | 123.0 (101.0, 179.0) | 0.710* | 98.0 (74.0, 138.0) | 112.5 (82.0, 153.0) | 0.054* |
| hs-CRP, mg/L | 0.79 (0.41, 1.91) | 0.59 (0.47, 1.50) | 0.645* | 0.53 (0.29, 1.19) | 0.66 (0.41, 1.27) | 0.055* |
| Urine albumin, mg/dL | 0.79 (0.43, 1.38) | 0.92 (0.50, 1.68) | 0.235* | 0.76 (0.43, 1.11) | 0.82 (0.74, 1.17) | 0.010* |
| Urine creatinine, g/dL | 0.133 (0.094, 0.169) | 0.127 (0.081, 0.165) | 0.393* | 0.094 (0.064, 0.128) | 0.081 (0.062, 0.111) | 0.139* |
| Urine albumin to creatinine ratio, mg/g | 6.85 (3.90, 10.76) | 7.81 (5.77, 11.98) | 0.121* | 8.50 (4.95, 13.15) | 10.88 (7.14, 16.55) | 0.002* |
| Estimated GFR | 78.0 (72.1, 85.7) | 79.7 (69.7, 86.1) | 0.953* | 75.1 (69.7, 80.7) | 73.0 (65.9, 79.1) | 0.190* |
| Current smokers (%) | 168 (43.6) | 22 (38.6) | 0.566 | 7 (1.1) | 0 (0.0) | 0.861 |
| Current drinkers (%) | 235 (61.0) | 40 (70.2) | 0.237 | 174 (26.2) | 15 (22.7) | 0.645 |
| Regular exercise (%) | 101 (26.2) | 15 (26.3) | 1.000 | 185 (27.8) | 11 (16.7) | 0.071 |
BP, blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; hs-CRP, high-sensitivity C-reactive protein; GFR, glomerular filtration rate; SD, standard deviation.
Values are expressed as mean (SD), number (%), or median (25th, 75th percentiles).
*p value from Mann-Whitney U test.
Baseline Characteristics of Premenopausal and Postmenopausal Women
| Premenopausal women | Postmenopausal women | |||||
|---|---|---|---|---|---|---|
| Without incident hypertension | With incident hypertension | Without incident hypertension | With incident hypertension | |||
| n (%) | 286 (95.6) | 13 (4.4) | 369 (88.1) | 50 (11.9) | ||
| Age, yrs | 45.6±3.7 | 46.5±3.2 | 0.391 | 56.8±7.1 | 60.3±6.1 | 0.001 |
| Body mass index, kg/m2 | 24.0±3.1 | 25.9±2.3 | 0.022 | 23.8±3.0 | 24.7±3.2 | 0.038 |
| Muscle mass, kg | 36.9±3.6 | 38.1±2.2 | 0.230 | 34.6±3.7 | 35.1±3.7 | 0.338 |
| Systolic BP, mm Hg | 113.2±10.7 | 118.1±8.5 | 0.107 | 115.3±11.0 | 121.3±10.3 | <0.001 |
| Diastolic BP, mm Hg | 72.4±7.9 | 73.8±5.1 | 0.508 | 73.3±7.3 | 75.8±6.9 | 0.022 |
| Fasting glucose, mg/dL | 89.0±9.9 | 90.8±11.4 | 0.502 | 89.9±11.6 | 90.5±10.0 | 0.728 |
| HDL-cholesterol, mg/dL | 48.8±9.9 | 47.1±14.2 | 0.679 | 48.4±10.6 | 46.0±8.3 | 0.065 |
| LDL-cholesterol, mg/dL | 108.9±28.5 | 119.0±26.5 | 0.209 | 123.0±30.5 | 124.2±28.9 | 0.786 |
| Triglycerides, mg/dL | 86.0 (67.0, 14.0) | 111.0 (83.0, 153.0) | 0.052* | 110.0 (81.0, 152.0) | 111.5 (82.0, 150.0) | 0.825* |
| hs-CRP, mg/L | 0.39 (0.24, 0.98) | 0.45 (0.39, 0.72) | 0.315* | 0.66 (0.36, 1.35) | 0.90 (0.49, 1.68) | 0.178* |
| Urine albumin, mg/dL | 0.75 (0.44, 1.11) | 0.79 (0.49, 0.85) | 0.961* | 0.76 (0.41, 1.10) | 0.88 (0.76, 1.28) | 0.007* |
| Urine creatinine, g/dL | 0.105 (0.069, 0.135) | 0.086 (0.068, 0.156) | 0.991* | 0.089 (0.063, 0.120) | 0.078 (0.062, 0.107) | 0.226* |
| Urine albumin to creatinine ratio, mg/g | 7.83 (4.68, 12.24) | 6.81 (4.87, 11.18) | 0.753* | 9.02 (5.26, 13.57) | 12.25 (8.52, 18.60) | 0.001* |
| Estimated GFR | 77.8 (72.1, 83.2) | 77.9 (67.6, 80.6) | 0.366* | 73.3 (67.8, 78.1) | 72.6 (65.2, 78.1) | 0.549* |
| Current smokers (%) | 3 (1.0) | 0 (0.0) | 1.000 | 4 (1.1) | 0 (0.0) | 1.000 |
| Current drinkers (%) | 96 (33.6) | 6 (46.2) | 0.524 | 74 (20.1) | 9 (18.0) | 0.878 |
| Regular exercise (%) | 87 (30.4) | 4 (30.8) | 1.000 | 94 (25.5) | 5 (10.0) | 0.025 |
BP, blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; hs-CRP, high-sensitivity C-reactive protein; GFR, glomerular filtration rate; SD, standard deviation.
Values are expressed as mean (SD), number (%), or median (25th, 75th percentiles).
*p value from Mann-Whitney U test.
OR for New-Onset Hypertension According to Baseline UACR Tertile
| UACR at baseline | ||||
|---|---|---|---|---|
| Tertile 1 | Tertile 2 | Tertile 3 | ||
| Men | ||||
| UACR, mg/g | <5.38 | 5.38–9.36 | ≥9.37 | |
| No. of subjects | 147 | 147 | 148 | |
| No. of new-onset hypertension | 14 (9.5%) | 20 (13.6%) | 23 (15.5%) | |
| OR (95% CI) for new-onset hypertension | ||||
| Model 1 | 1.00 | 1.47 (0.71–3.04) | 1.71 (0.84–3.48) | 0.146 |
| Model 2 | 1.00 | 1.58 (0.75–3.33) | 1.66 (0.79–3.48) | 0.187 |
| Model 3 | 1.00 | 1.65 (0.78–3.50) | 1.83 (0.85–3.94) | 0.124 |
| Women | ||||
| UACR, mg/g | <6.17 | 6.17–11.63 | ≥11.64 | |
| No. of subjects | 243 | 244 | 244 | |
| No. of new-onset hypertension | 11 (4.5%) | 24 (9.8%) | 31 (12.7%) | |
| OR (95% CI) for new-onset hypertension | ||||
| Model 1 | 1.00 | 2.20 (1.05–4.64) | 2.62 (1.27–5.40) | 0.008 |
| Model 2 | 1.00 | 2.59 (1.20–5.57) | 2.73 (1.29–5.78) | 0.012 |
| Model 3 | 1.00 | 2.57 (1.19–5.56) | 2.69 (1.27–5.73) | 0.014 |
UACR, urine albumin-to-creatinine ratio; OR, odds ratio; CI, confidence interval; BMI, body mass index; HDL, high-density lipoprotein; hs-CRP, high-sensitivity C-reactive protein; GFR, glomerular filtration rate.
Model 1: adjusted for age, Model 2: Model 1+additionally adjusted for baseline BMI, muscle mass, systolic blood pressure, diabetes mellitus, smoking, alcohol consumption, regular exercise, Model 3: Model 2+additionally adjusted for baseline fasting serum glucose, triglyceride, HDL cholesterol, hs-CRP, estimated GFR.
OR for New-Onset Hypertension According to Baseline UACR Tertile and Menopausal Status
| UACR at baseline | ||||
|---|---|---|---|---|
| Tertile 1 | Tertile 2 | Tertile 3 | ||
| Premenopausal women | ||||
| UACR, mg/g | <5.65 | 5.65–10.74 | ≥10.75 | |
| No. of subjects | 99 | 100 | 100 | |
| No. of new-onset hypertension | 4 (4.0%) | 5 (5.0%) | 4 (4.0%) | |
| OR (95% CI) for new-onset hypertension* | 1.00 | 1.18 (0.27–5.20) | 0.70 (0.15–3.28) | 0.718 |
| Postmenopausal women | ||||
| UACR, mg/g | <6.54 | 6.54–12.33 | ≥12.34 | |
| No. of subjects | 139 | 140 | 140 | |
| No. of new-onset hypertension | 7 (5.0%) | 19 (13.6%) | 24 (17.1%) | |
| OR (95% CI) for new-onset hypertension* | 1.00 | 3.49 (1.33–9.17) | 3.93 (1.53–10.11) | 0.006 |
UACR, urine albumin-to-creatinine ratio; OR, odds ratio; CI, confidence interval; BMI, body mass index; HDL, high-density lipoprotein; hs-CRP, high-sensitivity C-reactive protein; GFR, glomerular filtration rate.
*Adjusted for baseline age, baseline BMI, muscle mass, systolic blood pressure, diabetes mellitus, smoking, alcohol consumption, regular exercise, fasting serum glucose, triglyceride, HDL cholesterol, hs-CRP, estimated GFR.